Risk factors

CDT Equity (CDT) risk factors

Item 1A of every CDT Equity Inc. 10-K on file, and what changed from one year to the next.

Open CDT in Gloomberb →
  • FY2025 10-K risk factors

    38 risks, 3 dropped, 6 reworded since the prior year. Accumulated deficit grew to $68.3 million and net loss widened to $39.2 million for fiscal 2025. Nasdaq delisting threats materialized with low bid price warnings.

    Filed Apr 15, 2026
  • FY2024 10-K risk factors

    41 risks. CDT Equity is an early-stage clinical biopharmaceutical company facing significant net losses and ongoing funding needs.

    Filed Mar 28, 2025